Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0939c5e9137698ff8a8d8ddaa5ee7bf0 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
filingDate |
2001-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35ca0edc37e5c9ddba21bcc7cfd823fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1423043b2c1f347232a4701f5da5a23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6660e289b04471009340c44eefdfae2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d026e2c129c79aec44fd01f8a1ec68b |
publicationDate |
2003-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-0111058-A |
titleOfInvention |
Mesoprogestin 11 beta- [4- (hydroxyiminomethyl) -phenyl] -17 alpha-methoxymethyl-17 beta-methoxy-estra-4,9-dien-3-one solid forms |
abstract |
"Forms of 11 BETA- [4E- (HYDROXYIMINOMETHYL) -Phenyl] -17 ALPHA-METOXYMETHYL-17 BETA-METOXY-STRA-4,9-DIEN-3-ONA SOLES". The invention relates to novel solid body forms of 11β - [4E- (hydroxyiminomethyl) phenyl] -17β-methoxymethyl-17β-methoxy-estra-4,9-dien-3-one mesoprogestin (oxime J867), particularly a highly pure and stable highly crystalline or amorphous (non-solvate / non-hydrate) form of compound J867. The invention also relates to methods for producing said novel solid body forms and their use in pharmaceutical compositions. The new solid body shapes are characterized by displaying a high degree of stability. Oxime J867 solid body forms may in particular be employed in the area of fertility control and hormone replacement therapy. |
priorityDate |
2000-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |